Skip to main content
. 2013 Sep;23(9):1151–1158. doi: 10.1089/thy.2012.0565

Table 1.

Demographics of Included and Excluded Subpopulations

  Included (869) Excluded (63) p
Pretreatment TSH (mU/L) 1.75±0.94 2.88±4.2 <0.0001
Sex (male) 59.3% 47.7% 0.07
Ethnicity (white/other) 54.9%/45.1% 55.6%/44.4% 0.92
Smoking (current) 37.2% 38.1% 0.88
Iodine excess 58.9% 61.9% 0.64
Age (years) 44.3±11.3 46.9±10.3 0.08
Body mass index 25.9±4.9 26.9±5.5 0.17
Genotype 2 45.7% 47.6% 0.77
Sustained viral response 81.2% 85.7% 0.38
Fibrosis (none/severe) 80.3%/6.5% 87.1%/3.2% 0.19
Duration of infection (years) 4.5±5.5 5.0±5.3 0.52
Duration of therapy (weeks) 23.1±3.6 23.2±3.2 0.90

Excluded subjects were not different from the included euthyroid subjects except in having a higher rate of abnormal TSH (a specific exclusion criteria). Values are proportions, or means and standard deviation. All p-values represent the results of a proportion test or two-sided T-test as appropriate.

TSH, thyrotropin.